Sphera Funds Management’s KALA BIO KALA Stock Holding History

Sphera Funds Management’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-40	Closed	-$1.85M	–	127
2017 Q4	$1.85M	Buy	+40	New	+$1.87M	0.22%	98

Other funds holding KALA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sphera Funds Management's KALA Position: Q1 2018 in Review

Sphera Funds Management sold out of KALA BIO (KALA) in Q1 2018, closing a stake of 40 shares — an estimated $1.85M sold.

Sphera Funds Management first reported a position in KALA in Q4 2017 and held it in 1 quarter. The position peaked at $1.85M in Q4 2017. 64 funds tracked by Wall St. Rank hold KALA as of Q1 2018.

Sphera Funds Management reported no remaining KALA BIO position as of Q1 2018 after selling out during the quarter.
Sphera Funds Management sold 40 KALA BIO shares in Q1 2018, an estimated $1.85M.
Sphera Funds Management first reported a position in KALA BIO in Q4 2017 and held it in 1 quarter.
Sphera Funds Management's KALA BIO position peaked at $1.85M in Q4 2017.
64 funds tracked by Wall St. Rank held KALA BIO as of Q1 2018.

Based on Sphera Funds Management's 13F filing for Q1 2018, filed 10 May 2018.